Insulet Corp PODD

$149.29 -0.74 (-0.49%)

Valuation

Market cap
10,271,071,000
Revenue TTM
$2,708,100,000
Net income TTM
$247,100,000
P/E (trailing)
22.63
P/E (forward)
22.18
Profit margin
9.12%
Debt to equity
0.61

Trading

Volume
745,601
Avg volume
1,536,202
Day's range
$148.80 – $151.60
Shares out
69,371,000
Stochastic %K
27%
Beta
1.06
Analysts
Moderate Buy
Price target
$177.33

Price

Company profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values throu...

Show more

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
978 600 7000
Website
https://www.insulet.com
Address
100 Nagog Park, Acton, United States

Latest news

Stocktwits

GTA_Terminal Nov 9, 1:47 PM
Dark pool check on $PODD: what traded off the exchanges in the latest session. That came on a day the stock dropped hard, so the question is whether big holders were buying the dip or heading for the exit. Read the full article for the full details: https://globaltradersacademy.com/articles/podd-technical-levels-chart-options-flow-and-dark-pools-diverge-at-147?utm_source=stocktwits&utm_medium=social
0 replies
AXLFI_HQ Nov 8, 1:51 AM
The most recent Payout + Cash Flow signal on $PODD triggered on 2026-11-06. The expected return for the selected horizon is +6.19% with a historical profit probability of +57.76%. Learn more: https://axlfi.com/factors/stock/PODD/fund_payout_quality/daily?pass=eyJrIjoibGluayIsImUiOjE3OTQyNzU1MDR9.c8MiacDp-p2tFnNhgrEFFA
0 replies
anvesti Nov 6, 8:45 PM
Anvesti opened a long position $PODD · Entry $145.36 Model: ml_model_v3 · Score: 85.8
0 replies
NorthstarT1D Nov 6, 3:38 PM
$PODD they're going to buy back 10% of the free float. And the market is killing the stock...
1 replies
OnlyFibs Nov 5, 4:17 AM
$PODD 🚨 BULLISH WEDGE BREAKOUT | STRONG Q3 EARNINGS BEAT & $1B BUYBACK 🚨 $PODD is executing a clean 1W trendline breakout off its $145.00 – $160.00 Institutional Buy Zone! High-volume accumulation pushing toward $185.00 – $210.00 Resistance following Q3 earnings. 📊 CHART ZONES & BX ($PODD, 1W): • Smart Money Sell: $320.00 – $350.00 • Institutional Sell: $245.00 – $275.00 • Reclaim Target: $185.00 – $210.00 (CURRENT PUSH) • Institutional Buy: $145.00 – $160.00 (BREAKOUT BASE) • Smart Money Buy: $125.00 – $138.00 • BX Info: Monthly BX -21.9 ▲ | Weekly BX -13.0 ▲ (Strong expansion) 🎯 KEY LEVELS: 🐂 Bull Trigger: Defend $145.00, clear $185.00 to confirm daily structure & target $245.00+. 🐻 Bear Trigger: Weekly close below $125.00. BIAS: Bullish Trendline Breakout / Base Accumulation 📊📈 #hovdid
0 replies
KryptonResearch14 Nov 5, 3:35 AM
$PODD Gross margin hit 75.1 percent in Q3, up from 72.2 percent a year ago, and 90 basis points of that jump came from adjusting the warranty accrual tied to this year's voluntary device corrections, after fewer Pods needed replacing than first estimated. Cash went the other way in the filing. Nine month free cash flow was 211.7 million dollars vs 329.5 million a year ago, while inventories are up 22 percent since year end and receivables up 33 percent.
1 replies
anvesti Nov 4, 8:36 PM
Anvesti closed a long position $PODD 🟢 +18.51% $138.53 → $164.18 Model: ml_model_v3 · Score: 82.6 Reason: Profit Target · 14 days
0 replies
shoc24 Nov 4, 3:31 PM
$PODD reported earnings before the open today. Adjusted EPS beat estimates: $1.99 vs. $1.59 expected, according to Stock Meadow.
0 replies